Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health
TRES
Impacts of Time-Restricted Eating on Weight, Cardiometabolic and Cardiovascular Health in Patients With Acute Coronary Syndrome
1 other identifier
interventional
48
1 country
1
Brief Summary
The goal of this clinical trial is to learn about the effects of time-restricted eating in patients with history of acute coronary syndrome. The main questions it aims to answer are: 1) Is 10-hr TRE safe and feasible for patients with ACS; 2)What are the impacts of 10-hr TRE on anthropometric measurements, cardiometabolic health and cardiovascular health compared to ad libitum eating in patients with ACS?. Participants will be asked to limit eating duration to 10 hours daily.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2023
CompletedFirst Posted
Study publicly available on registry
August 23, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJuly 18, 2024
July 1, 2024
1 year
August 11, 2023
July 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in weight
unit: kg
4 weeks (pre- & post intervention)
Secondary Outcomes (17)
Change in lean body mass
4 weeks (pre- & post intervention)
Change in fat mass
4 weeks (pre- & post intervention)
Change in fasting glucose concentration
4 weeks (pre- & post intervention)
Change in fasting insulin concentration
4 weeks (pre- & post intervention)
Change in total cholesterol concentration
4 weeks (pre- & post intervention)
- +12 more secondary outcomes
Other Outcomes (2)
Rate of weekly compliance to intervention
4 weeks
Change in caloric intake
4 weeks (pre- & post intervention)
Study Arms (2)
Ad-libitum eating duration
NO INTERVENTION24 patients will be randomly assigned to the control group. Participants will be asked to continue usual eating duration. Participants will receive the standard care and heart-healthy nutrition education.
Time-restricted eating (TRE) duration
EXPERIMENTAL24 patients will be randomly assigned to the intervention group. Participants in this arm will be asked to limit the number of hours they eat in a day to 10 hours in addition to receiving the standard of care health and heart-healthy nutrition education.
Interventions
Time-restricted eating is a form of intermittent fasting. In this study, 10-hr TRE will be employed, where eating duration is limited to 10 hours. Participants are allowed to consume non-caloric beverages during fasting period.
Eligibility Criteria
You may qualify if:
- Adult, 18- 65 years old.
- Had history of acute coronary syndrome (ACS)
- Clinically stable
- Self-reported eating window of at least 12 h per day.
You may not qualify if:
- Severe obesity (body mass index ≥40 kg m-2).
- Unstable weight in the past three months (gain or lose more than 4 kg of weight).
- Unstable cardiovascular, renal, cardiac, liver, lung, adrenal, or nervous system disease that may compromise study validity.
- Any medications or supplements known to change sleep, circadian rhythms, or metabolism.
- Pregnant or lactating women.
- Perform overnight shift work more than one day/week on average.
- Regularly fasted for more than 15 hours/day or having completed twelve 24-hr fasts within the past three months).
- Active use of tobacco or illicit drug or history of treatment for alcohol abuse.
- Type I diabetes or diabetic, treated with insulin.
- Use of anti-obesity drugs or other drugs affecting body weight.
- Currently enrolled in weight loss or management programme, including surgical intervention.
- Severe kidney failure (glomerular filtration rate (GFR) \<30 mL/min).
- Eating disorder or current diagnosis of uncontrolled psychiatric illness, which may impair study involvement.
- Malignancy undergoing active treatment.
- Had gastrointestinal surgery or impaired nutrient absorption.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universiti Teknologi Maralead
- Ministry of Higher Education, Malaysiacollaborator
Study Sites (1)
Pusat Perkhidmatan Klinikal (CTC) UiTM
Kuala Selangor, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mazuin Kamarul Zaman, MMed Sc
Universiti Teknologi Mara
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 11, 2023
First Posted
August 23, 2023
Study Start
September 1, 2023
Primary Completion
September 1, 2024
Study Completion
September 1, 2025
Last Updated
July 18, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share